Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Management of Biological False Positive Syphilis Test Results

Understanding Syphilis Diagnostic Testing

  • The Centers for Disease Control and Prevention recommends that syphilis diagnosis requires both nontreponemal (RPR/VDRL) and treponemal (TPA/FTA-ABS) tests to be reactive 1
  • Nontreponemal tests like RPR can yield biological false positive results in many medical conditions unrelated to syphilis 1
  • The traditional testing algorithm begins with an inexpensive nontreponemal test (RPR), then confirms reactive specimens with a more specific treponemal test 1

Biological False Positive RPR Results

  • Biological false positive RPR results typically occur at low titers (≤1:8) 4
  • Multiple conditions can cause biological false positive RPR results, including autoimmune disorders, viral infections, pregnancy, advanced age, malaria, and injection drug use 4

Clinical Approach

  • No treatment for syphilis is indicated when the treponemal test is negative, as stated by the Clinical Infectious Diseases guidelines 2
  • Consider investigating for underlying conditions that may cause biological false positive RPR results 4
  • Testing for autoimmune disorders, viral infections, and other inflammatory conditions may be warranted 4
  • The specificity of RPR testing varies across studies but generally ranges from 95-98%, meaning false positives do occur 5, 4

Follow-up Recommendations

  • If clinical suspicion for syphilis remains high despite the negative treponemal test, consider repeat testing in 2-4 weeks to rule out very early primary syphilis 2
  • If clinical suspicion is low, no further syphilis testing is needed, as recommended by the Clinical Infectious Diseases guidelines 2

Pitfalls to Avoid

  • Do not treat for syphilis based solely on a reactive nontreponemal test without treponemal confirmation, as advised by the Centers for Disease Control and Prevention 1, 2
  • Avoid comparing titers between different test types (e.g., VDRL vs. RPR) as they are not directly comparable, according to the Clinical Infectious Diseases guidelines 3